Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 531.70
+2.70 (0.51%)
At close: Dec 4, 2025
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics had revenue of $3.68M USD in the quarter ending September 30, 2025, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $10.82M, up 24.05% year-over-year. In the year 2024, Lineage Cell Therapeutics had annual revenue of $9.50M with 6.19% growth.
Revenue (ttm)
$10.82M
Revenue Growth
+24.05%
P/S Ratio
37.68
Revenue / Employee
$140.47K
Employees
77
Market Cap
1.35B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.50M | 554.00K | 6.19% |
| Dec 31, 2023 | 8.95M | -5.76M | -39.16% |
| Dec 31, 2022 | 14.70M | 10.36M | 238.70% |
| Dec 31, 2021 | 4.34M | 2.52M | 137.73% |
| Dec 31, 2020 | 1.83M | -1.69M | -48.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |